Iovance Biotherapeutics Inc
IOVA
Market Cap$748.01M
Close$
$-0.15
107.1% downside
Current Fair Value
107.1% downsideOvervalued by 107.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $748.01 Million |
|---|---|
| Enterprise Value | $630.06 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.28 |
| Beta | 0.86 |
| Outstanding Shares | 322,868,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.93 |
|---|---|
| PEG | -68.3 |
| Price to Sales | - |
| Price to Book Ratio | 1.04 |
| Enterprise Value to Revenue | 2.96 |
| Enterprise Value to EBIT | -1.58 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Iovance Biotherapeutics Inc
CEO: Maria Fardis